You are here

bladder cancer

Merck's Keytruda shows up its rivals with NICE backing in bladder cancer

Fierce Pharma

Fri, 03/16/18 - 09:18 pm

How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment

Motley Fool

Thu, 03/15/18 - 09:55 am

prostate cancer

Merkel cell carcinoma

metastatic non-small cell lung cancer

metastatic breast cancer

In wake of Tecentriq bladder cancer bust and lost market share, Roche tries Tesaro combo

Fierce Pharma

Tue, 02/27/18 - 06:45 pm

PARP inhibitors

Bristol-Myers offers a positive snapshot on early data for an IDO1 rival to Incyte

Endpoints

Fri, 11/10/17 - 11:35 am

Bristol-Myers Squibb

cervical cancer

Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire

Fierce Pharma

Sat, 10/7/17 - 11:04 am

FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

Fierce Pharma

Tue, 09/12/17 - 10:00 pm

clinical trials

ESMO: Merck's Keytruda extends survival edge on its bladder cancer rivals

Fierce Pharma

Mon, 09/11/17 - 09:09 am

ASCO17: Merck touts Keytruda bladder benefit post Tecentriq failure

BioPharma Dive

Mon, 06/5/17 - 12:13 pm

Has Merck Lucked Into A $10 Billion Drug?

Forbes

Thu, 05/11/17 - 11:20 am

non-small cell lung cancer

In a stunning setback, Roche says its top cancer drug Tecentriq failed a key PhIII study

Endpoints

Wed, 05/10/17 - 10:13 am

clinical trials

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Fierce Pharma

Wed, 05/10/17 - 09:31 am

AstraZeneca's New Drug: Too Little, Too Late?

Seeking Alpha

Mon, 05/8/17 - 09:51 pm

Roche's Tecentriq wins FDA OK as first-line treatment in bladder cancer

Fierce Pharma

Tue, 04/18/17 - 09:00 pm

Merck KGaA, Pfizer get priority review for bladder cancer drug

Yahoo/Reuters

Tue, 02/28/17 - 10:22 am

Checkpoint inhibitors set to face off in bladder cancer

BioPharma Dive

Wed, 02/8/17 - 09:48 am

Bristol-Myers Squibb

FDA approves Bristol-Myers' Opdivo for bladder cancer

Yahoo/Reuters

Fri, 02/3/17 - 10:13 am

Bristol-Myers Squibb

Taris Biomedical closes enrollment in phase Ib trial for drug-device combo

Mass Device

Sat, 01/7/17 - 12:07 pm

drug-device combos

Your attention, please: AstraZeneca asks for a moment of rapt silence, for a BLA acceptance?

Endpoints

Sun, 12/11/16 - 11:57 am

Heat Biologics stock active on heels of lung, bladder cancer results

Bizjournals.com

Tue, 12/6/16 - 10:07 pm

Bristol’s Opdivo Has One Eye on Advanced Bladder Cancer

Market Realist

Tue, 11/22/16 - 11:29 am

Bristol-Myers Squibb

Pages